Indications for SUPARTZ FX:
Osteoarthritis of the knee in patients who have failed nonpharmacologic therapy and analgesics (eg, acetaminophen).
Prior to treatment: remove joint effusion, if present. Local anesthetic (eg, lidocaine) by SC inj may be recommended prior to inj. Inject 2.5mL intra-articularly in each affected knee weekly for 5 weeks. Use separate syringes for each knee.
Infection or skin disease at inj site.
Treatment cycle <3 injections: not established. Avian protein, feather, egg allergy. Avoid strenuous activity within 48hrs after injection. Pregnancy. Nursing mothers.
Avoid disinfectants with quaternary ammonium salts. Concomitant other intra-articular injectables: not established.
Arthralgia, arthropathy/arthrosis/arthritis, back pain, pain, inj site reaction/pain, headache.
Single-use prefilled syringes—1